Literature DB >> 12782849

Biocompatibility of the Ex-PRESS miniature glaucoma drainage implant.

Abraham Nyska1, Yoseff Glovinsky, Michael Belkin, Yoram Epstein.   

Abstract

PURPOSE: Based on lessons learned from earlier attempts, a novel miniature glaucoma implant, Ex-PRESS, was developed in 1998. The current study summarizes the histopathologic evaluation of this device implanted in the eyes of rabbits.
METHODS: The device was implanted into the anterior chamber at the corneoscleral junction in 1 eye each of 8 white New Zealand rabbits, while the contralateral eye served as control. Three and 6 months after implantation, the rabbits were killed and their eyes were enucleated and processed histologically, leaving the device in situ when sectioning.
RESULTS: Three and 6 months postoperatively, the local tissue reaction typically consisted of an enveloping, thin, mature, fibrotic capsule (thickness <0.04 mm), devoid of inflammatory cells. This capsule surrounded approximately 25% of the implant surface area present in the sections. The lumina of the devices were devoid of inflammatory exudates or other obstructions in all specimens examined, suggesting free flow of fluid.
CONCLUSIONS: The implantation of the Ex-PRESS miniature glaucoma shunt resulted in minimal capsular reaction. Considering the high reactivity of the rabbit eye, it is possible that this implant will induce a smaller cellular inflammatory reaction in the human eye.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782849     DOI: 10.1097/00061198-200306000-00017

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  23 in total

1.  Ex-PRESS implant.

Authors:  A Mermoud
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

2.  Optical coherence tomography of the Ex-PRESS miniature glaucoma implant.

Authors:  F D Verbraak; D M de Bruin; M Sulak; L A M S de Jong; M Aalders; D J Faber; T G van Leeuwen
Journal:  Lasers Med Sci       Date:  2005-04-28       Impact factor: 3.161

3.  Ex-PRESS implantation versus trabeculectomy in Chinese patients with POAG: fellow eye pilot study.

Authors:  Wei Wang; Min-Wen Zhou; Wen-Bin Huang; Xin-Bo Gao; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

4.  Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study.

Authors:  E Dahan; G J Ben Simon; A Lafuma
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

5.  Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.

Authors:  Alexandre Bissig; Michael Feusier; André Mermoud; Sylvain Roy
Journal:  Int Ophthalmol       Date:  2010-06-16       Impact factor: 2.031

6.  The ex-press mini glaucoma shunt: technique and experience.

Authors:  Steven R Sarkisian
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

Review 7.  Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome.

Authors:  Mohamed S Sayed; Richard K Lee
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

8.  Ex-PRESS implantation versus trabeculectomy in uncontrolled glaucoma: a meta-analysis.

Authors:  Wei Wang; Minwen Zhou; Wenbin Huang; Xiulan Zhang
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  Evaluation of bleb characteristics after implantation of the EX-PRESS™ glaucoma filtration device.

Authors:  Ashley E Laing; Leonard K Seibold; Jeffrey R SooHoo; Malik Y Kahook
Journal:  Mol Vis       Date:  2012-01-04       Impact factor: 2.367

10.  Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients.

Authors:  Sarwat Salim; Haiming Du; Sumalee Boonyaleephan; Jim Wan
Journal:  Clin Ophthalmol       Date:  2012-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.